• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Avive Welcomes Katerina Miras as Vice President of Marketing

    8/20/24 9:00:00 AM ET
    $BFLY
    Medical Electronics
    Health Care
    Get the next $BFLY alert in real time by email

    SAN FRANCISCO, Aug. 20, 2024 /PRNewswire/ -- Avive Solutions, Inc., a manufacturer of innovative Automated External Defibrillators (AEDs) and software solutions to improve access to AEDs and response to cardiac arrest emergencies, is excited to announce the appointment of Katerina Miras as their Vice President of Marketing. A visionary marketing leader with extensive experience in medtech, Miras brings a wealth of expertise in creating memorable healthcare brands that accelerate commercial growth.

    Avive Solutions, Inc. - a California-based AED manufacturer and developer of the Avive Connect AED, an innovative, connected automated external defibrillator (AED) (PRNewsfoto/Avive Solutions, Inc.)

    "I am honored to join Avive's leadership team at such a transformative time for the company. The opportunity to lead the marketing efforts for a mission-driven organization that is reshaping the AED industry motivates me. At Avive, we're driven by a simple truth: the status quo is no longer acceptable. For decades, cardiac arrest survival has been stagnant, but we have the power to change that. We're here to lead a revolution in pre-hospital emergency care, inspired by the vision of our founders, to give every life the opportunity to be saved when it matters most."

    KATERINA MIRAS, AVIVE'S VP of MARKETING

    With a strong track record of success, Katerina Miras has spent most of her professional career in various leadership roles within the medical device and healthcare technology industries. Prior to joining Avive, Miras was the Head of Marketing and Strategic Partnerships at Medivis, where she redefined the brand, being recognized as Fast Company's 2024 Innovation by Design Award and Most Innovative Companies Award. She also spearheaded strategic initiatives that led to significant market share growth and brand recognition. Before that, as Director of Marketing at Butterfly Network (NYSE:BFLY), Miras played a key role in shaping the brand, launching their first and second-generation products across human and veterinary verticals, and helped lead the company through its IPO. Miras is known for her ability to craft compelling narratives that resonate with both consumers and healthcare professionals.

    "We are excited to welcome Katerina to our leadership team at Avive. Her extensive experience in the healthcare sector and her proven ability to drive growth through innovative marketing strategies make her the perfect fit to lead our marketing efforts at this exciting time of growth for the Company," said Sameer Jafri, Avive's Co-Founder and CEO. "Katerina's leadership will be instrumental as we continue to expand our reach and work to solidify Avive's position as a leader in the AED industry."

    SAMEER JAFRI, AVIVE'S CO-FOUNDER AND CEO

    As Vice President of Marketing, Miras will focus on enhancing Avive's brand identity, driving awareness, and leading the company's marketing strategy as it continues to innovate in the AED and cardiac arrest response space. Her vision for the future includes not only increasing the presence of Avive's AEDs in key markets but also championing the company's mission to save lives by improving Sudden Cardiac Arrest outcomes through faster, more connected care.

    "What excites me most about Avive is the unwavering commitment from a team so passionate and dedicated to making a real, tangible difference," Miras shared. "It is clear that Avive believes in transforming moments of loss into stories of survival. Each of us has felt the pain of losing someone we love, but through our innovative technology, we bring hope. My personal vision is to ensure that in those critical moments, we can be there for the people who mean the most to us—so that another shared meal, another story told, and another cherished memory can be made with our loved ones."

    ABOUT AVIVE SOLUTIONS, INC.

    Avive Solutions is revolutionizing Sudden Cardiac Arrest response with innovative products that bring together a 21st-century AED device and first-of-its-kind software solutions. With the award-winning Avive Connect AED, Avive is the first new company to bring an AED to market in the U.S. in over 20 years. Focused on portability, accessibility, and connectivity, the Avive Connect AED is one of the most advanced products in the industry. Additionally, Avive's software solutions not only make owning and managing AEDs simple, they also deliver a comprehensive cardiac arrest response solution to everyone from individuals to entire communities, with the goal of increasing bystander intervention, decreasing time-to-defibrillation, and getting valuable data to the people who need it, when they need it. Founded in 2017, Avive is on a mission to empower bystanders, first responders, and 911 telecommunicators to provide lifesaving care as quickly and easily as possible. Learn more at avive.life.

    Media Contact:

    Kyle Noble

    Senior Marketing Manager

    Avive Solutions, Inc.

    [email protected]

    (415) 287-6881

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/avive-welcomes-katerina-miras-as-vice-president-of-marketing-302225789.html

    SOURCE Avive Solutions, Inc.

    Get the next $BFLY alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BFLY

    DatePrice TargetRatingAnalyst
    3/17/2025Outperform
    William Blair
    9/10/2024$3.00Buy
    Lake Street
    3/29/2023$2.25Neutral
    UBS
    11/29/2022$4.50Outperform
    Oppenheimer
    10/4/2022$9.50Buy
    B. Riley Securities
    12/17/2021$7.00Neutral
    UBS
    More analyst ratings

    $BFLY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Robbins Larry bought $262,251 worth of shares (244,774 units at $1.07) (SEC Form 4)

      4 - Butterfly Network, Inc. (0001804176) (Issuer)

      9/4/24 4:34:48 PM ET
      $BFLY
      Medical Electronics
      Health Care
    • Director Robbins Larry bought $1,683,373 worth of shares (1,676,869 units at $1.00) (SEC Form 4)

      4 - Butterfly Network, Inc. (0001804176) (Issuer)

      8/30/24 4:18:35 PM ET
      $BFLY
      Medical Electronics
      Health Care
    • President & CEO Devivo Joseph bought $98,519 worth of shares (104,000 units at $0.95), increasing direct ownership by 2% to 7,009,221 units (SEC Form 4)

      4 - Butterfly Network, Inc. (0001804176) (Issuer)

      8/7/24 4:34:48 PM ET
      $BFLY
      Medical Electronics
      Health Care

    $BFLY
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Butterfly Network's RoHS Lead Exemption Revocation Request Progresses to Stakeholder and Consultant Assessment

      Oeko-Institut appointed for third-party evaluation; stakeholder consultation will run June 6, 2025 - August 1, 2025 Butterfly Network, Inc. ("Butterfly", "the Company") (NYSE:BFLY), a digital health company transforming care with handheld, whole-body ultrasound, today announced that the European Commission has officially initiated the review and stakeholder consultation period for the Company's request to revoke Annex IV n. 14 of the European Commission's Restriction of Hazardous Substances (RoHS) Directive – a temporary exemption historically granted for lead in single crystal piezoelectric materials for ultrasonic transducers. Following Butterfly's revocation submission in October 202

      6/9/25 8:00:00 AM ET
      $BFLY
      Medical Electronics
      Health Care
    • AI in Healthcare Just Crossed a Tipping Point. Investors Are Watching These Names

      Equity Insider News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, June 4, 2025 /PRNewswire/ -- Equity Insider News Commentary – Generative AI is transforming healthcare faster than almost any other sector, according to a new McKinsey report. In a March survey of senior leaders across payers, providers, and healthcare services groups, 85% said they're actively using or exploring the technology. McKinsey's Global Institute estimates Gen AI could unlock $60–110 billion in annual value across pharma and medical products alone. With more AI pilot programs running than ever before, the tech world is racing to meet demand — including new efforts from Avant Technologies, Inc.

      6/4/25 2:36:00 PM ET
      $BFLY
      $MDT
      $ORCL
      $RXRX
      Medical Electronics
      Health Care
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Computer Software: Prepackaged Software
    • Healthcare's Quiet AI Boom Is Creating a New Class of Breakout Contenders

      Equity Insider News CommentaryIssued on behalf of Avant Technologies Inc. VANCOUVER, BC, May 27, 2025 /PRNewswire/ -- Equity Insider News Commentary – Artificial intelligence is rapidly becoming one of the most promising frontiers in healthcare innovation. Ark Invest's Cathie Wood recently pointed to breakthrough research from Mass General Brigham—where AI models identified cancer survival outcomes using facial photographs—as evidence that healthcare may become AI's "most profound application." As adoption moves from theory to practice, several tech and biotech players are already making real-world strides. Recent developments have come from Avant Technologies, Inc. (OTCQB:AVAI), Butterfly N

      5/27/25 9:45:00 AM ET
      $ATR
      $AZN
      $BFLY
      $RLAY
      Plastic Products
      Industrials
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $BFLY
    SEC Filings

    See more
    • Amendment: SEC Form SCHEDULE 13D/A filed by Butterfly Network Inc.

      SCHEDULE 13D/A - Butterfly Network, Inc. (0001804176) (Subject)

      6/17/25 8:02:11 PM ET
      $BFLY
      Medical Electronics
      Health Care
    • Butterfly Network Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - Butterfly Network, Inc. (0001804176) (Filer)

      6/17/25 4:15:24 PM ET
      $BFLY
      Medical Electronics
      Health Care
    • SEC Form 144 filed by Butterfly Network Inc.

      144 - Butterfly Network, Inc. (0001804176) (Subject)

      5/5/25 3:27:27 PM ET
      $BFLY
      Medical Electronics
      Health Care

    $BFLY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • William Blair initiated coverage on Butterfly Network

      William Blair initiated coverage of Butterfly Network with a rating of Outperform

      3/17/25 7:23:53 AM ET
      $BFLY
      Medical Electronics
      Health Care
    • Lake Street initiated coverage on Butterfly Network with a new price target

      Lake Street initiated coverage of Butterfly Network with a rating of Buy and set a new price target of $3.00

      9/10/24 8:07:39 AM ET
      $BFLY
      Medical Electronics
      Health Care
    • UBS initiated coverage on Butterfly Network with a new price target

      UBS initiated coverage of Butterfly Network with a rating of Neutral and set a new price target of $2.25

      3/29/23 7:12:28 AM ET
      $BFLY
      Medical Electronics
      Health Care